ACE |
Angiotensin converting enzyme |
aPL |
Antiphospholipid antibodies |
APS |
Antiphospholipid syndrome |
β2GPI |
Beta-2 glycoprotein I |
BMI |
Body mass index |
CAT |
Cancer associated thrombosis |
CI |
Confidence interval |
COVID19 |
SARS-CoV2 disease |
CVT |
Cerebral vein thrombosis |
DAMPs |
Damage-Associated Molecular Patterns |
DNA |
Desoxyribonucleic acid |
DVT |
Deep vein thrombosis |
ERS |
European Respiratory Society |
ESC |
European society of cardiology |
FVL |
Leiden factor V |
HR |
Hazard ratio |
ICU |
Intensive care unit |
IL |
Interleukin |
LAC |
Lupus anticoagulant |
MP |
Microparticles |
NETs |
Neutrophil extracellular traps |
NO |
Nitric oxide |
NOS |
nitrogen species |
OR |
Odds ratio |
PAI |
Plasminogen Activator Inhibitor-1 |
PAMPs |
Pathogen Associated Molecular Patterns |
PE |
Pulmonary embolism |
PGM |
Prothrombin G20210A Gene Mutation |
PLT |
Platelets |
PMNs |
Polymorphonuclear neutrophils |
ROS |
Reactive oxygen species |
RVT |
Residual venous thrombosis |
TF |
Tissue factor |
TLR |
Toll like receptor |
VTE |
Venous thromboembolism |
vWF |
Von Willebrand factor |
WBC |
White blood cells |